We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
+33.36%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.6B
AUM Growth
+$6.01B
Cap. Flow
-$1.19B
Cap. Flow %
-4.17%
Top 10 Hldgs %
11.57%
Holding
713
New
83
Increased
216
Reduced
260
Closed
78

Top Sells

Rank Stock Value
1
SHOP icon
Shopify
SHOP
+$122M
2
BABA icon
Alibaba
BABA
+$107M
3
DGX icon
Quest Diagnostics
DGX
+$107M
4
PFE icon
Pfizer
PFE
+$88.9M
5
DIS icon
Walt Disney
DIS
+$88.3M

Sector Composition

Rank Sector Weight
1 Technology 19.95%
2 Healthcare 14.63%
3 Consumer Discretionary 11.99%
4 Financials 11.51%
5 Industrials 10.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCN icon
326
FTI Consulting
FCN
$4.95B
$22.6M 0.08%
197,317
+62,273
+46% +$7.54M
FTDR icon
327
Frontdoor
FTDR
$5.16B
$22.5M 0.08%
+507,240
New +$20.7M
ROST icon
328
Ross Stores
ROST
$81B
$22.1M 0.08%
258,678
-8,089
-3% -$733K
DGX icon
329
Quest Diagnostics
DGX
$25.9B
$21.9M 0.08%
192,321
-1,004,604
-84% -$107M
VAR
330
DELISTED
Varian Medical Systems, Inc.
VAR
$21.9M 0.08%
178,710
-2,096
-1% -$243K
XPO icon
331
XPO
XPO
$23.4B
$21.5M 0.08%
803,712
+243,160
+43% +$5.82M
CNST
332
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$21.2M 0.07%
+706,985
New +$25.5M
GO icon
333
Grocery Outlet
GO
$906M
$21.1M 0.07%
516,965
+109,383
+27% +$3.91M
MRVL icon
334
Marvell Technology
MRVL
$165B
$21M 0.07%
600,061
+20,219
+3% +$592K
COO icon
335
Cooper Companies
COO
$14.2B
$20.8M 0.07%
293,116
-63,424
-18% -$4.7M
LHX icon
336
L3Harris
LHX
$50.7B
$20.7M 0.07%
121,900
-115,079
-49% -$21.6M
GM icon
337
General Motors
GM
$80B
$20.6M 0.07%
+814,077
New +$19.8M
DRE
338
DELISTED
Duke Realty Corp.
DRE
$20.5M 0.07%
580,032
-258,610
-31% -$8.83M
ETR icon
339
Entergy
ETR
$50.4B
$20.5M 0.07%
436,870
+31,618
+8% +$1.54M
EVRG icon
340
Evergy
EVRG
$19.2B
$20.4M 0.07%
344,574
-57,769
-14% -$3.42M
CDLX icon
341
Cardlytics
CDLX
$22.1M
$20.3M 0.07%
29,031
-5,490
-16% -$3.17M
ICHR icon
342
Ichor Holdings
ICHR
$2.61B
$20.3M 0.07%
762,542
-24,859
-3% -$568K
CRSP icon
343
CRISPR Therapeutics
CRSP
$4.77B
$20.2M 0.07%
274,917
-16,457
-6% -$962K
STL
344
DELISTED
Sterling Bancorp
STL
$20.1M 0.07%
1,715,745
-87,661
-5% -$1M
ICLR icon
345
Icon
ICLR
$12.8B
$20M 0.07%
118,716
+5,585
+5% +$880K
REAL icon
346
The RealReal
REAL
$1.44B
$19.8M 0.07%
1,547,568
+978,533
+172% +$11.6M
SDGR icon
347
Schrodinger
SDGR
$1.15B
$19.6M 0.07%
+214,114
New +$12.5M
CRUS icon
348
Cirrus Logic
CRUS
$6.65B
$19.4M 0.07%
313,432
+45,182
+17% +$3.09M
HR icon
349
Healthcare Realty
HR
$7.46B
$19.3M 0.07%
729,599
-18,775
-3% -$481K
CEVA icon
350
CEVA Inc
CEVA
$916M
$19.3M 0.07%
516,343
+158,283
+44% +$5.08M

Similar funds

Lord, Abbett & Co's Q2 2020 Portfolio in Review

As of Q2 2020, Lord, Abbett & Co held 713 positions worth $28.6B, up 27% from $22.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Lord, Abbett & Co withdrew a net $1.19B in Q2 2020, closing 78 positions and reducing 260 holdings. Its most notable exit was Raytheon Company, an estimated $87.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Lord, Abbett & Co opened a new position in Immunomedics Inc worth $117M.

  • Lord, Abbett & Co's largest Q2 2020 buy was Immunomedics Inc: 3,306,343 shares worth $117M.
  • Lord, Abbett & Co added most to Texas Instruments in Q2 2020, an estimated $99.4M increase.
  • Lord, Abbett & Co's biggest Q2 2020 reduction was Shopify, cutting an estimated $122M.
  • Lord, Abbett & Co fully exited Raytheon Company in Q2 2020, selling an estimated $87.9M.
  • Lord, Abbett & Co's ten largest holdings make up 12% of its $28.6B portfolio in Q2 2020.
  • Lord, Abbett & Co opened 83 new positions and closed 78 in Q2 2020.
  • Lord, Abbett & Co's portfolio value rose 27% quarter-over-quarter to $28.6B.

Based on Lord, Abbett & Co's 13F filing for Q2 2020, filed 14 Aug 2020.